Microbiology · us
Drug Resistance Does Not Always Emerge Gradually: Bacteria in the Lungs “Borrow Genes,” Making Pseudomonas aeruginosa Stronger in an Instant
Pathogens in the lungs of people with cystic fibrosis may not need to wait for a series of mutations. Simply receiving plasmids brought in by foreign bacteria can cause antibiotic resistance to surge by thousands or even more than ten thousand times. This study of human specimens rewrites the timescale on which drug resistance develops during infection.
In severe lung infections, one of the most challenging clinical situations is the sudden failure of drugs that had previously been able to suppress the pathogen. A study led by Washington University School of Medicine indicates that this shift may not result solely from pathogens gradually accumulating mutations. In the lungs of some patients, environmental bacteria that appear only briefly may directly transfer an entire set of resistance genes to existing pathogens, narrowing the treatment window within a very short time.
The research team analyzed lung specimens from people with cystic fibrosis. These patients are prone to chronic and severe respiratory infections and often receive intensive antibiotic treatment. The researchers observed that after treatment began in some patients, bacterial drug resistance did not rise slowly but instead surged by thousands of times, and in individual cases by more than ten thousand times. Such speed is difficult to explain fully through the commonly recognized process of gradual mutation.
The team initially used short-read sequencing to examine hundreds of bacterial isolates from patients but found no mutations sufficient to cause such extreme drug resistance. Only after switching to sequencing technology capable of reading longer, continuous DNA fragments did they identify newly acquired circular DNA—plasmids carrying resistance genes—in lung pathogens including Pseudomonas aeruginosa. The researchers then introduced these genes into bacteria that were originally susceptible to the drugs, confirming that the genes could indeed greatly increase drug resistance.
Evidence also pointed to the source of the plasmids: before drug resistance developed in some patients, environmental bacteria had been detected briefly in lung specimens, and these bacteria carried the same resistance plasmids as the pathogens. Experiments showed that they could transfer the plasmids to susceptible pathogens that had already established infections in the lungs. Genomic identity, the timing of their appearance, and functional tests together support the occurrence of “horizontal gene transfer” inside patients, although the study did not directly capture the exchange process in the lungs in real time.
The study, published in Nature Microbiology, gives new significance to environmental bacteria that were previously easy to regard as transient contaminants or low-virulence bystanders. Although they may not themselves cause the primary infection, they may act as gene carriers. If the same type of exchange transfers not only drug resistance but also the ability to acquire nutrients, disrupt immune responses, or breach tissue barriers, pathogen behavior could change rapidly during a single infection. However, these broader risks currently remain possibilities proposed by the researchers and were not individually confirmed by this study.
The study also leaves important limitations. The publicly available information does not specify the number of patients, which antibiotics were involved, the incidence of transfer events, or whether the findings can be generalized to ordinary pneumonia or infections in other organs. The evidence is therefore not yet sufficient to directly change treatment guidelines. What it establishes more clearly is a monitoring challenge: if clinical sequencing is designed primarily to detect point mutations, it may miss entire segments of foreign DNA. In the future, in addition to tracking pathogens, it may be necessary to identify transiently coexisting microorganisms and mobile plasmids, and to assess whether blocking gene exchange has practical value for prevention and control.